In the 6-mo landmark cohort, ToT was longer in patients who received additional LT, although the association did not reach statistical significance (hazard ratio [HR]: 0.54, 95% confidence interval [CI]: 0.27–1.10, p = 0.088).
← all excerpts
Role of Local Treatment to the Prostate in Patients With de Novo Low-volume Metastatic Hormone-sensitive Prostate Cancer Receiving Androgen Receptor Pathway Inhibitors.
1
0.0880
0.0880